These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28850195)

  • 1. Anti-HCV immunoblot indeterminate results in blood donors: non-specific reactivity or past exposure to HCV?
    Kiely P; Styles C
    Vox Sang; 2017 Aug; 112(6):542-548. PubMed ID: 28850195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.
    Kiely P; Kay D; Parker S; Piscitelli L
    Transfusion; 2004 Mar; 44(3):349-58. PubMed ID: 14996191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second- or third-generation EIA: overlap of false-positive reactivity and its impact on donor management.
    Kiely P; Wilson D
    Transfusion; 2000 May; 40(5):580-4. PubMed ID: 10827263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of the meaning of indeterminate results of the recombinant immunoblot assay for hepatitis C virus in blood donors.
    Piro L; Solinas S; Luciani M; Casale A; Bighiani T; Santonocito D; Girelli G
    Blood Transfus; 2008 Apr; 6(2):107-11. PubMed ID: 18946955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
    Pereira FM; Zarife MA; Reis EA; G Reis M
    Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
    Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
    Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
    Cavazza S; Lagging M
    Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors.
    Melve GK; Myrmel H; Eide GE; Hervig T
    Transfusion; 2009 Nov; 49(11):2359-65. PubMed ID: 19702654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of nonprimate hepacivirus-related genomes in blood donors seroreactive for hepatitis C virus displaying indeterminate blot patterns.
    Levi JE; Cabral SP; Nishiya A; Ferreira S; Romano CM; Polite MB; Pereira RA; Mota MA; Kutner JM
    J Viral Hepat; 2014 Nov; 21(11):e164-6. PubMed ID: 24689976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hepatitis C virus (HCV) core-specific antibody suggests occult HCV infection among blood donors.
    Quiroga JA; Avellón A; Bartolomé J; Andréu M; Flores E; González MI; González R; Pérez S; Richart LA; Castillo I; Alcover J; Palacios R; Carreño V; Echevarría JM
    Transfusion; 2016 Jul; 56(7):1883-90. PubMed ID: 27185049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of a modified version of the ARCHITECT Anti-HCV test in detecting samples with immunoblot-confirmed, low-level antibody to hepatitis C virus.
    Echevarría JM; Avellón A; Jonas G; Hausmann M; Vockel A; Kapprell HP
    J Clin Virol; 2006 Apr; 35(4):368-72. PubMed ID: 16406797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivity.
    Hitziger T; Schmidt M; Schottstedt V; Hennig H; Schumann A; Ross S; Lu M; Seifried E; Roggendorf M
    Transfusion; 2009 Jul; 49(7):1306-13. PubMed ID: 19309471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
    Myrmel H; Navaratnam V; Asjø B
    J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection.
    Dufour DR; Talastas M; Fernandez MD; Harris B; Strader DB; Seeff LB
    Clin Chem; 2003 Mar; 49(3):479-86. PubMed ID: 12600961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective analysis of different algorithms for the diagnosis of hepatitis C virus infection.
    Barreto AM; Takei K; E C S; Bellesa MA; Salles NA; Barreto CC; Nishiya AS; Chamone DF
    Braz J Med Biol Res; 2008 Feb; 41(2):126-34. PubMed ID: 18235967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.